Current Research Studies at the Fisher Center

The Fisher Center is involved in the following genetic counseling research studies funded by the National Institutes of Health (NIH):

Personal Aid to Health (PATH): Decision Making Interventions for Women Receiving Uninformative BRCA1/2 Test Results or Positive BRCA1/2 Test Results

  • Randomized clinical trial evaluating decision support materials that supplement standard information provided during genetic counseling
  • Assesses the impact of decision support materials on patient decision-making about breast and ovarian cancer risk management strategies
  • Women may be asked to participate if they undergo genetic counseling/testing at one of these participating sites: Georgetown University Lombardi Comprehensive Cancer Center (primary site); Ohio State University Comprehensive Cancer Center (Columbus, OH), and Virginia Piper Cancer Institute (Minneapolis, MN)
  • Funded by the National Institutes of Health (National Human Genome Research Institute and National Cancer Insitute), and the Fisher Center for Hereditary Cancer and Clinical Genomics Research

 

The Genetic Education for Men (GEM) Trial: 

Web-Based Genetic Education vs. Standard Care in Men from Hereditary Cancer Families

  • Randomized clinical trial among untested men from families with BRCA1 or BRCA2 (BRCA) mutations
  • Participants receive either individually tailored, interactive, internet-based genetic education or usual care (i.e., standard resources)
  • Participants have the option of obtaining phone-based genetic counseling by board-certified, experienced genetic counselors affiliated with the study as well as BRCA testing
  • Assesses men’s attitudes about genetic counseling and testing and health care decisions
  • Untested men may be asked to participate if a female relative tested positive for a BRCA1/2 mutation and  she was a patient or research participant at Georgetown University Lombardi Comprehensive Cancer Center or MedStar Georgetown University Hospital
  • Participating site:  Georgetown University Lombardi Comprehensive Cancer Center
  • Funded by the National Institutes of Health/National Cancer Institute

 

Evolving Model of Cancer Susceptibility Testing:  Clinical Decisions and Outcomes

  • Observational study  evaluating women’s decision making about testing for BRCA1/2 and other genes associated with hereditary breast/ovarian cancer (i.e., multigene or panel testing) 
  • Assesses psychological and behavioral outcomes after testing
  • Women may be asked to participate if they undergo genetic counseling/testing at a collaborating site, the Genetics Risk Assessment Program at Virginia Cancer Specialists (Arlington, Fairfax, and Alexandria)
  • Funding to Georgetown University Lombardi Comprehensive Cancer Center by the National Institutes of Health/National Cancer Institute and the Fisher Center for Hereditary Cancer and Clinical Genomics Research

 

 

*If you have been invited to participate in one of these studies or are currently entrolled and you have questions, you may contact us at 877-687-2720 (toll-free) or fisher.research@georgetown.edu

These studies are limited to individuals who receive genetic counseling at one of the participating study sites.

To make an appointment for genetic counseling and testing for hereditary cancer risk, please call (202) 444-0023

This page has been updated on 3/19/18